BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 9626129)

  • 1. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome.
    Seippel L; Bäckström T
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1988-92. PubMed ID: 9626129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
    Hammarbäck S; Damber JE; Bäckström T
    J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of plasma norepinephrine cyclicity, increased estradiol during the follicular phase, and of progesterone and gonadotrophins at ovulation in women with premenstrual syndrome.
    Blum I; Lerman M; Misrachi I; Nordenberg Y; Grosskopf I; Weizman A; Levy-Schiff R; Sulkes J; Vered Y
    Neuropsychobiology; 2004; 50(1):10-5. PubMed ID: 15179014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of induced menses on symptoms in women with premenstrual syndrome.
    Schmidt PJ; Nieman LK; Grover GN; Muller KL; Merriam GR; Rubinow DR
    N Engl J Med; 1991 Apr; 324(17):1174-9. PubMed ID: 2011161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
    Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
    J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition.
    Hale GE; Hughes CL; Burger HG; Robertson DM; Fraser IS
    Menopause; 2009; 16(1):50-9. PubMed ID: 18978637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one.
    Wang M; Seippel L; Purdy RH; Bãckström T
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1076-82. PubMed ID: 8772579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential response to estrogen challenge test in women with and without premenstrual dysphoria.
    Eriksson O; Bäckström T; Stridsberg M; Hammarlund-Udenaes M; Naessén T
    Psychoneuroendocrinology; 2006 May; 31(4):415-27. PubMed ID: 16359822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
    Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle.
    Reame NE; Marshall JC; Kelch RP
    Psychoneuroendocrinology; 1992; 17(2-3):205-13. PubMed ID: 1359599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased follicular phase gonadotropin secretion is associated with impaired estradiol and progesterone secretion during the follicular and luteal phases in normally menstruating women.
    Schweiger U; Laessle RG; Tuschl RJ; Broocks A; Krusche T; Pirke KM
    J Clin Endocrinol Metab; 1989 May; 68(5):888-92. PubMed ID: 2497129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.
    Nippoldt TB; Reame NE; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1989 Jul; 69(1):67-76. PubMed ID: 2499593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteal phase defects in the rhesus monkey: the significance of serum FSH:LH ratios.
    Wilks JW; Hodgen GD; Ross GT
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1261-7. PubMed ID: 826543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics.
    Andersch B; Abrahamsson L; Wendestam C; Ohman R; Hahn L
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):657-64. PubMed ID: 575318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle.
    Roseff SJ; Bangah ML; Kettel LM; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1033-9. PubMed ID: 2507568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.